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A B S T R A C T
Two unspeciﬁc peroxygenases (UPO, EC 1.11.2.1) from the basidiomycetous fungi Marasmius rotula and
Marasmius wettsteinii oxidized steroids with hydroxyacetyl and hydroxyl functionalities at C17 - such as corti-
sone, Reichstein's substance S and prednisone - via stepwise oxygenation and ﬁnal ﬁssion of the side chain. The
sequential oxidation started with the hydroxylation of the terminal carbon (C21) leading to a stable geminal
alcohol (e.g. cortisone 21-gem-diol) and proceeded via a second oxygenation resulting in the corresponding α-
ketocarboxylic acid (e.g. cortisone 21-oic acid). The latter decomposed under formation of adrenosterone (4-
androstene-3,11,17-trione) as well as formic acid and carbonic acid (that is in equilibrium with carbon dioxide);
ﬁssion products comprising two carbon atoms such as glycolic acid or glyoxylic acid were not detected. Protein
models based on the crystal structure data of MroUPO (Marasmius rotula unspeciﬁc peroxygenase) revealed that
the bulky cortisone molecule suitably ﬁts into the enzyme's access channel, which enables the heme iron to come
in close contact to the carbons (C21, C20) of the steroidal side chain. ICP-MS analysis of puriﬁed MroUPO
conﬁrmed the presence of magnesium supposedly stabilizing the porphyrin ring system.
1. Introduction
Steroidal compounds inﬂuence animals and humans in various ways
[1,2]. They comprise several biologically active classes of substances
such as bile acids, cardio-active drugs (cardiotonics), steroid sapo-
genins, steroid alkaloids as well as sexual and corticosteroidal hor-
mones [3]. As hormones, they regulate metabolic and ontogenetic
processes in humans from fetal life to adulthood. Because of their
biological eﬀects, steroids are not only of general scientiﬁc interest but
also of medical relevance, not least with respect to pharmaceutical
applications. In animals including humans, steroids are made from la-
nosterol that derives from cyclization of the triterpene squalene, which
for its part is a product of the mevalonate pathway [4]. One group of
pharmaceutically relevant steroids are C21 hormones (pregnane core),
which include gluco- and mineralocorticoids produced in the adrenal
cortex as well as their precursor progesterone. The latter can be
transformed via hydroxylation to 17α-hydroxy progesterone and sub-
sequent side chain removal or C21 hydroxylation to androstenedione
and 11-deoxycortisol (Reichstein's substance S), respectively; the
former is the direct precursor of the male sexual hormone testosterone
and the latter of the glucocorticoid cortisol. Both Reichstein's substance
S and androstenedione are important intermediates in industrial steroid
syntheses.
Steroids used for therapeutic or other pharmaceutical purposes are
largely products of partial synthesis starting from animal cholesterol or
herbal phytosterols or sapogenins. The addition, removal and mod-
iﬁcation of functional groups to, from and at these starting materials is
of central importance when producing the wide variety of steroidal
drugs. These modiﬁcations are achieved using conventional organic
synthesis and/or microbial whole-cell biotransformations [5,6]. Cyto-
chrome P450 enzymes (P450s, CYPs) are the key biocatalysts of steroid
biotransformation and catalyze hydroxylation, epoxidation, ar-
omatization and side chain removal [2]. Such reactions are integral part
of steroid biosynthesis pathways in humans and animals (see above)
and some of them can be also found in microorganisms (fungi, bac-
teria); typically in form of single transformations with often unknown
function for the microbes (e.g. 11α-, 11β- and 16α-hydroxylation by
Bacillus, Mycobacterium, Curvularia or Cunninghamella) [6,7]. However,
microbial systems do not mimic all relevant human steroid transfor-
mations. Thus side-chain removal (CeC bond cleavage) from
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progesterone or pregnenolone is exclusively accomplished by verte-
brate CYP17A1 (also known as a 17α-hydroxylase/17,20-lyase). It
proceeds through two intrinsic reactions: in the ﬁrst one, the enzyme
hydroxylates the 17α-position and in the second reaction, it cleaves the
CeC bond between C17 and C20 in a lyase-like reaction resulting in the
release of acetate [8]. To our best knowledge, however, steroids hy-
droxylated in position C21 such as Reichstein's substance S, cortisol or
cortisone are not subject of C-C cleavage by CYP17A1 or any microbial
P450. Since, on the other hand, Reichstein's substance S is a key pre-
cursor in industrial steroid syntheses [9], it would be worthwhile to
have a catalyst that selectively removes the respective hydroxyacetyl
moiety to form the corresponding keto-derivatives (17-ones).
Unspeciﬁc peroxygenase (UPO, EC 1.11.2.1) is a secreted fungal
enzyme type that eﬃciently transfers oxygen from peroxides (R-OOH)
to diverse substrates including unactivated hydrocarbons [10]. Lit-
erally, such enzymes strictly follow the peroxide “shunt” pathway of
P450s and in this context, they can reach total turnovers numbers of
104 to almost 106 for oxygen transfer reactions [11–13]. As P450s, UPO
enzymes are heme-thiolate proteins but they do not share any sequence
homology with them. Highest sequence homology has been ascertained
to fungal chloroperoxidase (CPO, EC 1.11.1.6) that is actually a UPO
with strong halide oxidation activity [14]. Among the UPO-catalyzed
reactions are hydroxylations, epoxidations, O- and N-dealkylations,
oxidations of organic hetero atoms and bromide as well as one-electron
oxidations. Their catalytic cycle involves formation of a highly reactive
oxoferryl intermediate (compound I) and a protonated basic compound
II (oxoferryl hydroxide) that are the active oxygen species in hydro-
xylation reactions [15,16]. Crystal structure of the UPO from Agrocybe
aegerita (AaeUPO) was solved and has given ﬁrst insights into the mo-
lecular organization of this exceptional peroxidase type [17,18].
Here we report two UPOs from the mushrooms Marasmius rotula
(MroUPO) [19] and Marasmius wettsteinii (MweUPO, novel wild-type
UPO ﬁrst described herein), which catalyze the selective deacylation of
17α,21-dihydroxycorticosteroids. To our best knowledge, this reaction
has not been reported so far for any microbial P450 and represents a
new reaction type for UPOs.
2. Materials and methods
2.1. Chemicals
Formic acid (pro analysis) and acetonitrile (ACN, gradient grade for
liquid chromatography) were purchased from VWR (Darmstadt, Ger-
many). All other chemicals including cortisone (S I), prednisone (S II),
Reichstein's substance S (S III), and adrenosterone (P III) were obtained
from Sigma-Aldrich GmbH (Schnelldorf, Germany) in the highest
available purity.
2.2. Enzyme preparation and characterization
The extracellular peroxygenases from the basidiomycetous fungi
Agrocybe aegerita (AaeUPO; main isoform, 46 kDa) andMarasmius rotula
(MroUPO; main isoform, 32 kDa denaturated and 58 kDa native) were
produced and puriﬁed as described previously [19,20]. The enzyme
preparations were homogeneous according to sodium dodecyl poly-
acrylamide gel electrophoresis (SDS-PAGE) and analytical high per-
formance liquid chromatography-size exclusion chromatography
(HPLC-SEC). The speciﬁc activities of the AaeUPO and MroUPO pre-
parations were 99.6 Umg−1 and 26.0 Umg−1, respectively. One unit
(1 U) corresponds to the oxidation of 1 μmol of veratryl alcohol (3,4-
dimethoxybenzyl alcohol) to veratraldehyde (3,4-dimethox-
ybenzaldehyde) in 1min at 23 °C [20]; activity measurements were
performed in 50mM sodium phosphate buﬀer at pH 7.0 (AaeUPO) or
5.5 (MroUPO and MweUPO).
A novel wild-type peroxygenase was produced with Marasmius
wettsteinii (MweUPO) strain 582 deposited at the culture collection of
the International Institute Zittau (Technical University of Dresden,
Germany) and at DSMZ Braunschweig (Deutsche Stammsammlung für
Mikroorganismen und Zellkulturen, Germany) under DSM 106021. The
fungus was isolated from fruiting bodies growing on spruce needle litter
(Picea abies) near the Kottmar mountain in East Saxony (Germany) in
September 2015 (more information on the fungal species is given in the
Supplemental Information section). Stock cultures were maintained in
culture slants on 2% malt extract agar at 4 °C in the dark. For enzyme
production, the content of a completely overgrown agar-plate was
homogenized in 80mL sterile tap water and used for the inoculation of
liquid cultures (5% vol/vol of the suspension). Submerged cultivation
was performed in 500-mL Erlenmeyer ﬂasks containing 200mL of a
complex liquid medium according to Gröbe et al. [19] on a rotary
shaker (120 rpm, at 23 °C). The time course of MweUPO production is
shown in Fig. S1. Fungal cultures were harvested after three weeks
when the UPO activity had reached approximately 2500 U L−1. Crude
extracts of concentrated culture liquid contained at least ﬁve isoforms
of MweUPO. The major isoform was isolated via diﬀerent steps of fast
protein liquid chromatography (FPLC) and had a ﬁnal speciﬁc activity
of 37.5 Umg−1; the corresponding puriﬁcation table is given in Table
S1. Homogeneity of the ﬁnal MweUPO preparation was proven by SDS-
PAGE and HPLC-SEC and compared to MroUPO and AaeUPO (Fig. S2
and S3). Molecular mass of the native enzyme was 62 kDa (determined
by HPLC-SEC; Fig. S2) and 32.5 kDa according to denaturing SDS-PAGE
(Fig. S3) indicating, as in the case of MroUPO, a physiological dimer
[21]. HPLC-SEC of puriﬁed MweUPO was carried out using an Agilent
Series 1200 instrument equipped with a diode array detector (Agilent
Technologies Deutschland GmbH, Waldbronn, Germany) and a Yarra
3 μ SEC-2000 column (300×7.8mm, Phenomenex, Aschaﬀenburg,
Germany). Separation of UPO proteins was achieved at 25 °C under
isocratic conditions (ﬂow rate 1mLmin−1) with sodium acetate/so-
dium chloride (50mM/100mM, pH 6.9) as eluent. Calibration occurred
with a gel ﬁltration low-molecular weight calibration kit from GE
Healthcare (Munich, Germany). SDS-PAGE was performed as described
previously [22].
2.3. Enzymatic reaction setup
Typical reaction set-ups (0.2–1.0mL) contained UPO protein
(1.0–2.0 UmL−1 corresponding to 0.04–0.08 μM=0.014–0.028
mgmL−1), 0.5–2.0 mM steroidal substrate (stock solution in 50% ACN
resulting in a ﬁnal ACN concentration of 5 vol%) and 50mM potassium
phosphate buﬀer (pH 7.0 or 5.5). The reactions stirred at room tem-
perature were started with H2O2 by either adding it directly (0.1 to
2mM H2O2) or supplying it continuously with a syringe pump
(0.5mM h−1 for 4 h). For kinetic studies, aliquots were taken from the
reaction mixtures every 20min and analyzed by high performance li-
quid chromatography-mass spectrometry (HPLC-MS).
The reaction setup was scaled up to 50mL to separate and purify the
products of enzymatic steroid conversion for subsequent NMR analysis.
The reaction solution contained 20 U (5.6 μgmL−1) of puriﬁed
MroUPO, 80mg of the substrate (S I cortisone, S II prednisone or S III
Reichstein's substance S; chemical structures are shown in Fig. 1),
2.5 mL of ACN (ﬁnal concentration of 5% vo/vol) and potassium
phosphate buﬀer (50mM, pH 5.5). The reaction was started by the
addition of hydrogen peroxide (H2O2, 1mM) and repeated every 6min
over 1 h (ﬁnal concentration 10mM).
2.4. Analytical methods
2.4.1. HPLC-MS method I (for standard reactions)
Products of enzymatic syntheses were analyzed by high perfor-
mance liquid chromatography (HPLC) using an Agilent Series 1200
instrument equipped with a diode array detector and an electrospray
ionization mass spectrometer (ESI-MS) (Agilent Technologies Deutsch-
land GmbH, Waldbronn, Germany). Unless otherwise stated, reverse
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phased chromatography on a Luna C18 column (2mm diameter by
250mm length, 3 μm particle size, Phenomenex, Aschaﬀenburg, Ger-
many) was used. Column was eluted at a ﬂow rate of 0.2 mLmin−1 and
40 °C with aqueous 0.01% vol/vol ammonium formate (pH 3.5)/ACN,
95:5 for 5min, followed by a 15-min linear gradient to 100% ACN.
Mass spectrometric measurements were made in positive or negative
ESI mode in a mass range from 70 to 900, step size 0.1, drying gas
temperature 350 °C, capillary voltage 4000 V for positive mode and
5500 V for negative mode. Reaction products were identiﬁed relative to
authentic standards, based on their retention times, UV absorption
spectra, and mass spectral data ([M+H] or [M−H] ions).
2.4.2. HPLC-MS method II
Additional analyses were performed using a Kinetex C18 column
(2mm diameter by 250mm length, 5 μm particle size, Phenomenex),
which was eluted with a ﬂow rate of 1mLmin−1 at 40 °C with aqueous
0.01% vol/vol ammonium formate (pH 3.5)/ACN, 95:5 for 2min, fol-
lowed by a 12-min linear gradient to 100% ACN. MS parameters were
the same as described under method I.
2.4.3. HPLC-MS method III
Kinetic studies on the conversion of cortisone by MroUPO and
MweUPO were carried out by applying a more rapid HPLC method.
Respective samples were analyzed using a Phenomenex Kinetex Phenyl-
Hexyl column (2.6 μm particle size, 150×2.1mm). The ﬂow rate was
0.4 mLmin−1 and the temperature set to 40 °C. The following gradient
of 0.01 vol% ammonium formate (pH 3.2) and ACN was performed:
0–0.2min 20% ACN followed by a linear gradient to 65% ACN
(0.2–10min) and to 85% (10–12min). The MS parameters were the
same as in method I.
2.4.4. Ion chromatography (IC) method for organic acids
Organic acids were analyzed by IC using a Dionex Series ICS1100
system (Thermo Fisher GmbH, Idstein, Germany) ﬁtted with an IonPac®
ICE-AS1 column (4mm diameter by 250mm length, Dionex, Ger-
mering, Germany). The column was eluted at 30 °C and 1.6 mLmin−1
with an aqueous perﬂuorobutyric acid solution (1mM) over 20min.
Products were identiﬁed relative to the authentic standards by their
retention times.
HPLC-UV method for organic acids. Analyses were performed using
a Rezex™ ROA-Organic Acid H+ (8%) column (7.8mm diameter by
300mm length, Phenomenex). The column was eluted at 50 °C and
0.5 mLmin−1 with an aqueous sulfuric acid solution (0.005 N) over
25min. Acids were recorded at 210 nm and identiﬁed relative to au-
thentic standards by their retention times.
2.5. Product isolation
Products of enzymatic steroid oxidation were separated and puriﬁed
by preparative HPLC using a 1260 Inﬁnity Agilent system (Agilent
Technologies Deutschland GmbH) equipped with a Kinetex C18 column
(Axia packed, 21.2 mm diameter by 150mm length, 5 μm particle size,
Phenomenex), which was eluted at 20mLmin−1 and room temperature
with water/ACN 70:30 for 1min under isocratic conditions, followed
by a 5-min linear gradient to 70% ACN and a 1.5-min gradient to 100%
CAN, which was hold for 0.5min and then set to 30% ACN within
1min. Eluting peaks (detected at 240 nm) were sampled with an
Inﬁnity fraction collector (fraction collector; preparative scale, G1364B,
Agilent Technologies Deutschland GmbH). The purity of isolated pro-
ducts was checked by analytical HPLC-MS (method I above).
2.6. NMR spectroscopy experimental conditions
2.65mg of P I and 0.5mg of P II were transferred into capillary
NMR tubes of 2.5× 100mm in 150 μL dimethylsulfoxide-d6 (99.8%,
Deutero, Kastellaun, Germany). Proton, COSY (correlated spectro-
scopy), HSQC (heteronuclear single quantum coherence) and HMBC
(heteronuclear multiple bond correlation) spectra were recorded on a
Bruker Avance 500MHz spectrometer equipped with a 2.5mm selective
inverse SEI probe (Bruker, Rheinstetten, Germany). For technical rea-
sons, some HMBC spectra had to be recorded on a Bruker Avance III
600MHz instrument equipped with a 1.7mm inverse SEI probe (part of
the sample was transferred in to 1.7× 100mm microtubes). For che-
mical shift prediction, the ACD/C+H NMR predictors, release 2015,
pack2, from ACDlabs (Toronto, Ontario, Canada) were used.
2.7. Precipitation of carbon dioxide with barium hydroxide
Carbon dioxide (CO2) formation in the course of side chain removal
from cortisone was qualitatively proved in a separate experiment. Two
vials ﬁlled with 1mL of saturated barium hydroxide [Ba(OH)2] were
connected via silicon tubes with two further vials containing the reac-
tion mixture with MroUPO (active sample) or a control without enzyme
(Fig. S7). The reaction occurred under helium atmosphere. Before
starting the reaction, the intrinsic CO2 was stripped by ﬂushing with
helium, over 10min. Afterwards the reaction was started as described
Fig. 1. Chemical structures of corticosteroids used in this study: S I cortisone
(A), S II prednisone (B) and S III Reichstein's substance S (C).
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above but under continuous bubbling of helium through the vials. The
stripped gaseous compounds were transferred into the Ba(OH)2 vials
where the CO2 was trapped as insoluble barium carbonate (BaCO3;
compare Fig. S7).
2.8. Determination of the metal content in MroUPO
Puriﬁed MroUPO was washed with deionized water resulting in a
ﬁnal protein concentration of 4 μM determined by a standard Bradford
assay. Inductively coupled plasma optical emission spectroscopy (ICP-
OES) and ICP mass spectrometry (ICP-MS) were performed on an Op-
tima 3000 system and an Elas DRC-e device (both PerkinElmer Inc.,
MA, USA), respectively. The OES-system was calibrated with the ‘ICP
multi-element standard solution IV’ (Mg, K, Ca, Mn, Fe, Cu) as well as
the ‘phosphorus ICP standard’ (both Merck, Darmstadt, Germany) in
1mg L−1 and 10mg L−1 concentrations. Deionized water served as
enzyme blank solution. Measurements were performed according to the
manufacturers' speciﬁcations. Diﬀerent concentrations (2, 15, and
50 μg L−1) of the ‘ICP multi-element standard solution VI’ (V, Mn, Fe,
Co, Cu; Merck, Darmstadt, Germany) were used to calibrate the MS
unit.
2.9. Crystal structure and 3D-modelling
The crystal structure data of MroUPO have been made available
recently (protein data bank entries 5FUJ and 5FUK). Based on them,
ﬁrst structures were published indicating that MroUPO is a dimeric
protein with a relatively wide heme access channel [21]. Cortisone was
docked into theMroUPO active site cleft using the open-source program
AutoDock Vina, version 1.1.2 [23]. The MroUPO structure (PDB 5FUJ)
and the cortisone molecule (3D conformation obtained from PubChem
[24], CID 222786; 4 rotatable bonds) were prepared for docking in
AutoDockTools [25], version 1.5.6. In order to deﬁne the active site of
MroUPO, cortisone as substrate was ﬁrst placed manually at the en-
trance of the protein's binding pocket using PyMOL (The PyMOL Mo-
lecular Graphics System, Version 2.0 Schrödinger, LLC). The grid box
was centered at x: −10.607, y: −17.81 and z: −28.584 with sizes of
20.25, 16.5, and 9.75Å, respectively. Exhaustiveness was tested be-
tween 8 and 100. No more than twenty output poses (energy range
5 kcal mol−1 with a maximum number of 30 for binding modes) were
generated. In separated runs, the best three models occurred re-
peatedly. The docking model with highest aﬃnity (−8.3 kcal mol−1) in
all runs shows close proximity of cortisone C21 to heme iron (4.4 Å) and
is shown in Fig. 6.
3. Results
3.1. Enzymatic conversion of cortisone (S I)
Both MroUPO and MweUPO were found to be capable of converting
Fig. 2. Time courses of the conversion of cortisone by MroUPO and MweUPO. Analyses were carried out by HPLC at 240 nm. Data are given in mAU*s of the
respective peak areas (top) and in μM (bottom) along with the residual UPO activities (bottom). Black circles - cortisone (S I), blue up-pointing triangles - product P I
(cortisone 21-gem-diol, m/z 376), red diamonds - product P II (cortisone 21-oic acid, m/z 374), green squares - product P III (adrenosterone, m/z 300), brown crosses
- sum of peak areas, black asterisks - cortisone (S I) control, orange down- pointing triangles - residual UPO activity. Arrows mark the point of complete substrate
consumption (S I, cortisone). Reaction solutions contained 1 UmL−1 UPO, 0.5 mM cortisone (S I) in 10mM potassium phosphate buﬀer (pH 5.5). H2O2 was supplied
by syringe pump at 0.5 mMh−1. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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cortisone (S I, m/z M+H+: 361) by almost 100%, while AaeUPO did
not accept this compound as substrate. For the ﬁrst 20min of the re-
action, we calculated turnover numbers (TON) of 6.4min−1 and
6.1 min−1, respectively. These TON were limited by the limited amount
of H2O2 gently and continuously supplied via a syringe pump, which
would theoretically entail a maximum TON of 6.9min−1 under the
conditions applied (co-substrate limitation to prevent heme damage).
The ﬁrst product that appeared within 20min had a molecular mass of
376 (P I; m/z M+H+: 377) indicating a hydroxylated metabolite
(Fig. 2). 20min later, a second product was detectable with a molecular
mass of 374 (P II; m/z M+H+: 375) probably representing an oxida-
tion product of P I. P II showed an unusual peak shape (tailing) in the
HPLC elution proﬁle that is characteristic for keto-enol tautomerism or
the presence of an aldehyde hydrate (that is in equilibrium with the
corresponding free aldehyde). After 80min, the formation of P I had
reached its maximum, while the peak of P II still increased. 160min
after starting the reaction, a third product (P III) emerged with a smaller
mass of 300 (m/z M+H+: 301); it was identiﬁed by means of an au-
thentic standard as adrenosterone and simultaneously, P II started to
decrease (Fig. 2). At the end of the experiment (after 220min), only
20% of P II's maximum peak area remained, while P III reached a
maximum concentration of 359 and 347 μM in the case of MroUPO and
MweUPO, respectively. The respective results are summarized in
Figs. 2, 3 and S5. Compared to the Marasmius UPOs, AaeUPO merely
converted S I to negligible extent (< 1%), which resulted in traces of P
II and P III (Fig. 3).
The observed HPLC peak pattern and the almost identical UV
spectra of substrate and products, caused by the unchanged chromo-
phore (double bonds in the steroidal A ring), prompted us to analyze
the MS data more in detail to identify possibly hidden additional pro-
ducts. Indeed, the hint of an additional mass eluting at the same time as
the substrate (S I) was observed. Therefore, the HPLC method was
modiﬁed and improved (among others by changing the stationary
phase). Then, we analyzed the extracted ion counts of the respective MS
data (given in Fig. S5 forMweUPO) again and found a fourth product (P
IV; most likely 17-hydroxy-3,11-dioxoandrost-4-ene-17-carboxylic
acid) with a molecular mass of 346 (m/zM+H+: 347). Fig. S5 displays
a further metabolite (P V) with a mass of 316 (m/z: 317M+H+),
probably a hydroxylation product of the ﬁssion product P III. Both P IV
and P V were only detectable in traces and could not be quantiﬁed
because of lacking standards; thus changes in their concentration were
deduced from the corresponding peak areas (based on UV-absorption).
3.2. NMR spectroscopic analysis of the products P I and P II
Particular eﬀorts were made to unambitiously identify the products
P I, P II and P III by 13C/1H NMR spectroscopy. The NMR assignment of
P I was based on the analysis of the side chain resonances in conjunc-
tion with chemical shift prediction and comparison to cortisone re-
ference spectra (Table S2). In the side chain, a CH signal at 84.1/
5.39 ppm indicating an alcoholic substitution was observed along with
a carbonyl function at 207.0 ppm. Two possible keto-enol tautomeric
structures were considered. The COSY showed that the CH signal at
84.1/5.39 ppm couples to two OH doublets at 6.12 and 6.36 ppm, re-
spectively. Moreover, we observed HMBC correlations between the
carbonyl resonance at 207.0 ppm and the CH proton at 5.39 ppm and
the OH protons at 6.12 and 6.36 ppm. Furthermore, we observed HMBC
couplings between the carbon at 84.05 ppm and two OH (6.12 and
6.36 ppm). This clearly establishes P I to be structure 1 (cortisone 21-
gem-diol) given in Fig. 4, along with an additional minor species in the
same sample (P Ia accounting for approximately 14%). The structure of
P Ia being the hydrate of an aldehyde prompted us to further inspect the
heteronuclear spectra: Fig. 4 shows the aldehyde section of the re-
spective HMBC spectrum. A correlation between a CH at 9.66/
195.2 ppm (spread by its 1J (C,H) coupling of 189 Hz) and a carbonyl C
at 200.5 ppm (showing a 2J (C,H) coupling of 27 Hz) indicates the
presence of the free aldehyde P Ia (cortisone 21-al) in the sample
(Fig. 4).
For the second metabolite (Table S3), P II, we suggest the structure
of a carboxylic acid (cortisone 21-oic acid) given in Fig. 5. Inspection of
the proton, COSY and HSQC spectra showed that the sterane scaﬀold
resonances were unchanged, while side chain CH resonances could not
be observed. An additional OH proton resonance appeared at 7.09 ppm
(integral one proton). Unfortunately, the sample's concentration was
too low to observe the carbonyl 13C signals, through neither direct 13C
NMR nor HMBC.
P III was the major product at the end of the reaction (with about
70% yield) and identiﬁed as adrenosterone (4-androst-ene-3,11,17-
trione) by means of an authentic standard. As the corresponding ﬁssion
products, we found traces of formic acid (HCOOH) and carbonic acid
(H2CO3) by ion chromatography (IC; data not shown) and HPLC with
UV detection (Fig. S6). In addition, the formation of carbon dioxide
Fig. 3. HPLC elution proﬁles of reaction solutions containing cortisone (S I,
0.5 mM) and 1 UmL−1 of three diﬀerent UPOs; they were recorded after dif-
ferent reaction times (0–220min). H2O2 was supplied by syringe pump at
0.5 mM h−1 over the indicated time. A) MroUPO, B) MweUPO and C) AaeUPO.
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(that is in equilibrium with carbonic acid and bicarbonate) in the re-
action solution was conﬁrmed by the formation of a whitish smear of
precipitating barium carbonate (BaCO3) when gaseous substances
formed were stripped from the reaction solution and ﬂushed through a
barium hydroxide solution (Fig. S7). Unexpectedly, glycolic acid (HO-
H2C-COOH) and glyoxylic acid (OHC-COOH) – the supposed ﬁssion
products – were not detectable in the reaction solutions. On the other
hand, glycolic acid was found to be a substrate of MroUPO that was
rapidly oxidized into glyoxylic acid, formic acid and carbon dioxide as
proved by HPLC-UV, IC and BaCO3 formation (data not shown).
The residual UPO activity in the reaction solution followed an in-
teresting biphasic time course (both forMroUPO andMweUPO). As long
as S I and P I were present in the reaction solution, the enzyme activity
remained rather stable, however, after their consumption (between 120
and 140min), the activity strongly decreased, probably caused by un-
favorable catalysis during conversion of P II into the ﬁnal product P III
(Fig. 2).
The conversion of prednisone (S II) and Reichstein's substance S (S
III) by MroUPO and MweUPO gave similar results as for S I. Both
compounds were converted in three ways following the mass changes
Δm/z=+16, Δm/z=+14 and Δm/z=−60. The latter mass in-
dicates that the last step was again a side chain removal resulting in the
formation of 4-androsten-3,17-dione and 1,4-androstadien-3,11,17-
trione, respectively (data not shown). AaeUPO oxidized S II and S III to
negligible extent (< 1%) with traces of S (−60) as sole product.
3.3. Structure and metal content of MroUPO
Based on the recently published coordinates and ﬁrst crystal struc-
ture of MroUPO [21], we performed a docking analysis using cortisone
(substrate S I) as ligand and MroUPO as receptor with the open-source
program AutoDock Vina. Corresponding Fig. 6 shows that the corti-
costeroid molecule almost perfectly ﬁts into the active site of MroUPO,
while exposing the side chain to be removed towards the reactive heme
center. In the computed model, cortisone's C21 appears in close
proximity to the heme iron (4 Å). The binding pocket virtually consists
just of aliphatic residues (leucine, Leu; isoleucine, Ile) and contains
merely one aromatic residue (phenylalanine, Phe). One polar serine
Fig. 4. Chemical structure of the cortisone metabolite P I with a molecular mass of 376.44 gmol−1 and the molecular formula C21H28O6 conﬁrmed by NMR (left) as
well as the corresponding dehydrated aldehyde P Ia being in equilibrium with P I. Bottom: HMBC spectrum of P I indicating the presence of the corresponding free
aldehyde (P Ia).
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residue (Ser156) is also found in this pocket; however, this residue does
seemingly not form polar contacts to cortisone in the best ﬁtting
docking models. The keto groups at C3 and C11 of cortisone lie outside
the binding pocket. The hydroxyl group at C17 as well as the keto group
at C20 do not have polar contacts to amino acid residues of MroUPO. In
the second best ﬁtting model (with correct orientation of the hydro-
xyacetyl group to heme but slightly less binding aﬃnity of
−8.2 kcal mol−1), these both oxygen functionalities build intra-mole-
cular contacts. The hydrogen of the hydroxyl group at C21 can build a
polar contact to the hydroxyl‑oxygen of the carboxylic group of a glu-
tamate (Glu157, the distal acid-base catalyst) and thereby stabilizes
correct substrate binding.
Since magnesium (Mg) had been found in the crystal structure of
AaeUPO [18], we checked whether MroUPO does also contain this
probably stabilizing metal. ICP-MS and ICP-OES analyses in fact re-
vealed that Mg was along iron (Fe) the most abundant metal in puriﬁed
MroUPO. Its amount corresponded to nearly one mol Mg per UPO
molecule (Table S4). In contrast, the concentration of other metals,
including manganese (Mn) and calcium (Ca) reported to be present in
other heme peroxidases [26–28], were noticeably lower.
4. Discussion
Two UPOs from the mushroom genus Marasmius (MroUPO,
MweUPO) were found to convert corticosteroids with hydroxyacetyl
(-CO-CH2OH) and alcohol (-OH) functionalities at C17 via stepwise
oxygenation/oxidation and ﬁnal removal of the side chain (C-C clea-
vage, deacylation). In contrast, the model enzyme AaeUPO known to
oxidize diverse other substrates, failed in catalyzing this reaction
[10,29]. In a previous study, three UPOs including AaeUPO and
MroUPO were shown to hydroxylate steroids with longer side chains
(with 8–10 carbon atoms) such as cholesterol, ergosterol and sitosterol
preferably at tertiary C25, their scission, however, was not observed
[30]. Another UPO from the ascomycetous mold Chaetomium globosum
(CglUPO) has recently been demonstrated to selectively epoxidize (at
4,5-position) testosterone that is neither a substrate of MroUPO nor of
AaeUPO [31].
The ability of MroUPO and MweUPO to convert bulky substrates
such as cortisone (S I), prednisone (S II) and Reichstein's substance S (S
III) can be attributed to the size and molecular architecture of the en-
zymes' active site. Both Marasmius enzymes belong to the cluster
(subfamily) of “short” UPOs whereas AaeUPO is a “long” UPO that
diﬀers in several features from the former ones [29]. Thus, the heme
access channel ofMroUPO is about 4 Å shorter and up to 5 Å wider than
that of AaeUPO. Furthermore, the hydrophobic amino acid residues
ﬂanking the heme access channel are diﬀerent. While AaeUPO contains
nine rigid Phe and one Tyr forming a rather narrow “carafe-shaped”
heme channel (Fig. 7B), MroUPO's heme channel comprises only one
Phe but ten more ﬂexible aliphatic amino acids (1 Ala, 2 Leu, 7 Ile;
Fig. 6) and thus forms a rather open and symmetric frustum (Fig. 7A)
[18]. These structural diﬀerences may explain, which is why MroUPO
(and also MweUPO that shares> 90% sequence identity with MroUPO,
unpublished result) harbor and convert bulky substrates such as corti-
costeroids whereas AaeUPO cannot (Fig. 6).
A plausible reaction sequence involving the stepwise oxygenation
Fig. 5. Proposed structure of metabolite P II with a molecular mass of
374.43 gmol−1 and following molecular formula: C21H26O6.
Fig. 6. 3D-model of MroUPO when harboring cortisone (S I, in magenta) as substrate (MroUPO-cortisone complex). Left side: intersection of MroUPO with bound
cortisone; middle: detailed view of the substrate channel (heme access channel) including catalytic residues Glu-157 (distal acid-base catalyst) and His-86 (charge
stabilizer). Polar contacts of the hydroxyl group at C21 of cortisone are shown as yellow dashed lines; right side: top view of the substrate channel with and without
bound cortisone (all residues forming the substrate channel are depicted and labeled). For convenience of the reader, the stabilizing magnesium ion (green ball) is
shown in all views.
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and ﬁnal deacylation of cortisone-and related substrates (S I–III) by
MroUPO (and respectively by MweUPO) can be described as follows. In
the ﬁrst step, the enzymes hydroxylates the position C21 in the side
chain by means of H2O2 (peroxygenation) resulting in the formation of
P I that is a geminal alcohol (21-gem-diol, aldehyde hydrate) being in
equilibrium with the corresponding free aldehyde (cortisone 21-al, P Ia)
(Fig. 8). A similar reaction was observed during the oxidation of 5-
hydroxymethylfurfural (HMF) by AaeUPO (or aryl alcohol oxidase)
leading to the corresponding dialdehyde (diformylfurane), about 50%
of which was in equilibrium with its stable hydrate (gem-diol detectable
by MS) [32,33].
In the next step, the Marasmius UPOs catalyze a second hydroxyla-
tion leading to the corresponding α-ketocarboxylic acid P II (corstisone
21-oic acid). However, so evident the structure of P II is (compare re-
spective NMR data), so uncertain is the exact point of enzymatic attack
at P I. This is due to the diﬀerent tautomeric and hydrated forms of P I.
Theoretically – in addition to P I and P Ia (the latter detected by NMR,
Table S2) – two further tautomeric structures, a 21-endiol and an α-
hydroxy-21-oic acid, are conceivable; all of them would be substrates of
Marasmius UPOs and converted into P II. In our opinion, the most
probable route may proceed via the hydroxylation of the free aldehyde
(P Ia; Fig. 8). This reaction type via abstraction of hydrogen (C-H ab-
straction) and OH-rebound has been reported for various UPO sub-
strates including aromatic (e.g. benzaldehyde) and aliphatic (n-alka-
nals) aldehydes, which are oxidized into the corresponding carboxylic
acids (e.g. benzoic acid and n-alkanoicfatty acids, respectively) [34,35].
An alternative route may start from the 21-gem-diol and proceed via an
additional hydroxylation at C21 to form a putative 21-gem-triol that
spontaneously dehydrates under formation of the 21-oic acid, Fig. 8). A
third variant may follow the hydroxylation of the α-hydroxy-21-oic
acid tautomer of P I to give the corresponding 20-gem-diol that dehy-
drates to P II; eventually, the epoxidation of the tautomeric 21-enediol
could contribute to P I conversion as well (not shown). Corticosterone
with the same hydroxyacetyl moiety as cortisone (but lacking OH at
C17) was reported to be analogously oxidized by a panel of liver CYPs
(especially of the CYP3A and CYP4A subfamilies), involving 21-gem-
diol, 21-gem-triol and 21-al intermediates and resulting in the ﬁnal
formation of the corresponding 21-oic acid [36].
The last step in the conversion of corticosteroids byMarasmius UPOs
proceeds via the removal of the side chain, which results, in the case of
P II, in the appearance of adrenosterone (17-one, P III) (Fig. 9). Al-
though the formation of the latter compound was unambiguously de-
monstrated (by an authentic standard), it is the most diﬃcult-to-explain
step of the reaction sequence [37] (Fig. 9). Taking into consideration
the existing knowledge on steroidal side-chain removal by 17α-hydro-
xylase/C17,20-lyase (CYP17A1) [8], recently described UPO-catalyzed
fatty acid decarboxylation [21] and existing knowledge on chemical
decarboxylation of α-ketoacids by hydrogen peroxide [38,39], it ap-
pears to be plausible that P II undergoes both enzymatic and chemical
oxidation in the course of side-chain removal (Fig. 9). Thus, a lyase-like
reaction resulting in CeC bond scission between C17 and C20, release
of glyoxylic acid (that is immediately oxidized/cleaved by UPO to
formic acid and CO2/carbonic acid) and the formation of a new double
bond at C17 (carbonyl, P III) is as conceivable as the peroxide-driven
oxidation of P II (caused by the peroxo-anion/HOO– at the pH used
[38]), which results via a peroxo-intermediate in the release of CO2 and
a C17-ol/C17-oic acid derivative (P IV, the mass of which ﬁts to the
detected m/z [H+] of 347); in a ﬁnal spontaneous step, less stable P IV
may decay to formic acid and P III (17-one) (Fig. 9). Whether a com-
pound-0-like UPO-intermediate (i.e. a bound peroxo-anion-heme spe-
cies) is involved as proposed for the C17,20-lyase reaction of CYP17A1
remains unclear [40]. The rapid inactivation of Marasmius UPOs during
the obviously unfavorable conversion of P II into P III may support this
assumption (Fig. 2).
The presence of equimolar amounts of magnesium (Mg2+) in pur-
iﬁed MroUPO conﬁrms the importance of this metal as structural ele-
ment in UPO proteins. Strong indication of its presence were also found
in the crystal structure of AaeUPO and it was detected by ICP-MS/OES
analysis in highly pure preparations of the enzyme [18]. It may stabilize
the porphyrin ring system that is under permanent ring strain. Inter-
estingly, the Mg ion sits at the same position as Mn2+ in manganese
peroxidase (MnP, EC 1.11.13.1) [41]. In both cases, the metals are
chelated by conserved acidic amino acid residues (Glu, Asp) and the
heme propionate [18,41]. The presence of manganese was proposed for
CPO based on its crystal structure (but without appropriate metal
analysis) [26]. However, when considering the function of Mn in MnP
[42] and the almost identical covalent atomic radiuses of Mn2+
(1.39 Å) and Mg2+ (1.41 Å) [43], it is more conceivable that redox-
inactive Mg2+ is present in CPO representing a halide-oxidizing UPO
[14].
5. Conclusions
After recently reported fatty acid shortening by MroUPO [21],
steroidal side-chain removal is the second example of a C-C cleaving
Fig. 7. Tangential cross sections through crystal structure-based 3D-models of
MroUPO and AaeUPO; the former (A) has a rather open and symmetric frustum-
like heme access channel whereas that of the latter (B) is narrower and “carafe-
shaped”.
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reaction (deacylation) catalyzed by this enzyme type. Thereby another
prototypical reaction of P450s (in this case lyase-activity of CYP17A1)
with physiological and biotechnological relevance could be ascertained
for a secreted fungal peroxygenase. Future studies will have to elucidate
the role of UPO compound 0 and whether other fungal UPOs (of
which>4000 sequences are known so far) may catalyze similar reac-
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Fig. 8. Postulated reactions involved in the side chain oxi-
dation of S I (cortisone) by MroUPO and MweUPO. First hy-
droxylation at C21 results in P I (cortisone 21-gem-diol,
identiﬁed by NMR) that is in equilibrium with the corre-
sponding free aldehyde P Ia (cortisone 21-al, also identiﬁed
by NMR). Both P I and P Ia can be subject of a second hy-
droxylation at C21 resulting in the direct formation of P II
(cortisone 21-oic acid, detected by NMR) or in putative cor-
tisone gem-triol# that is in equilibrium with P II.
Fig. 9. Possible reaction sequences explaining the side chain removal from P II (cortisone 21-oic acid) by MroUPO and MweUPO. 1) A lyase-like activity of UPO
similar to that described in [44] may cleave the CeC bond between C17 and C20 resulting in P III (adrenosterone, identiﬁed by an authentic standard) and putative
glyoxylic acid that can be cleaved by UPO into formic acid and carbonic acid/carbon dioxide (as demonstrated by authentic standards and barium carbonate
precipitation). 2) P II may also chemically react with H2O2 to form a tetrahedral intermediate [38] that decomposes to carbon dioxide and P IV (17-hydroxy-3,11-
dioxoandrost-4-ene-17-carboxylic acid, as indicated by mass data).
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